miR-21 can exacerbate dextrose sodium sulphate (DSS)-induced colitis by affecting the gut microbiota [174], while miR-193a-3p has been reported to ameliorate DSS-induced colonic inflammation by affecting the absorption of bacterial products via targeting PepT1 [68,175]. The gene discussed is SLC15A1; the disease is colitis.